Hdl particle size
Pro Research Analysisby 
Searched over 200M research papers
HDL Particle Size: Structure and Determinants
High-density lipoprotein (HDL) particles are a diverse group of nanoparticles that vary in size, structure, and protein composition. The size of HDL particles is mainly determined by the number of apolipoprotein molecules on their surface and the amount of cholesterol esters in their core. Larger HDL particles generally contain more triglycerides and apolipoproteins such as apoC-I, apoC-II, and apoC-III, while smaller particles have different lipid and protein compositions Melchior2021Kuklenyik2019Lima2004.
Apolipoprotein A-I (APOA1) and apolipoprotein A-II (APOA2) are key proteins influencing HDL particle size. HDL particles containing only APOA1 (LpA-I) are primarily found in two distinct sizes, while the presence of APOA2 increases the range of particle sizes, contributing to greater size heterogeneity . Additionally, specific chemical modifications of APOA1, such as fatty-acylation, are associated with larger HDL particles .
Methods for Measuring HDL Particle Size
Several laboratory techniques are used to separate and measure HDL particle sizes, including size-exclusion chromatography, polyacrylamide gradient gel electrophoresis, nuclear magnetic resonance (NMR) spectroscopy, and laser-light scattering. These methods allow for the identification of multiple HDL subfractions, each with characteristic size ranges, typically from about 6.8 nm to over 11 nm in diameter Kuklenyik2019Ong2023Lima2004.
HDL Particle Size and Function
HDL particle size is closely linked to its physiological functions. Larger HDL particles (HDL2) are often associated with greater cardioprotective properties, while smaller HDL particles (HDL3) may have different roles in cholesterol transport and metabolism . The rate at which apolipoprotein A-I exchanges with HDL particles is faster in smaller particles, suggesting that particle size can influence HDL's ability to participate in cholesterol efflux and other metabolic processes .
Clinical Associations of HDL Particle Size
HDL particle size has been studied as a marker for cardiovascular and metabolic risk. Smaller HDL particle size is associated with a less favorable metabolic profile and higher risk of coronary heart disease, particularly in men compared to women . In chronic heart failure, larger HDL particle size and a higher cholesterol-to-particle ratio are linked to increased risk of cardiovascular death, mainly due to a reduction in the proportion of small HDL particles .
In chronic kidney disease, HDL particle size is reduced, and these changes are related to disease severity and may contribute to HDL dysfunction . In older adults, HDL particle size is significantly associated with HDL efflux capacity, a measure of HDL's ability to remove cholesterol from cells, although particle size itself may not directly predict atherosclerotic plaque presence after adjusting for other risk factors .
HDL Subclasses and Disease Risk
HDL particles are often categorized into small, medium, and large subclasses. Studies show that higher concentrations of small and medium HDL particles are independently associated with lower risk of both cardiovascular events and chronic inflammation-related diseases, supporting the idea that smaller HDL particles have important anti-inflammatory properties .
Conclusion
HDL particle size is determined by its protein and lipid composition, especially the presence and modification of apolipoproteins. Measurement of HDL size provides insights into its function and potential role in disease risk. Both the size and subclass distribution of HDL particles are important markers for cardiovascular and metabolic health, with smaller particles often linked to protective effects against inflammation and heart disease.
Sources and full results
Most relevant research papers on this topic